FTSE 250 movers: SVG surges on full-year results while Acacia suffers
Updated : 14:32
The FTSE 250 was in the green in Friday afternoon trading, after banking shares were rattled by news US authorities have asked Deutsche Bank for $14bn to settle an investigation.
Among the leading risers was SVG Capital, after it posted its results for the six months to 31 July on Friday, with a net asset value per share of 735p at period end - a 12% increase in the six months.
The firm reported a significant uplift from currency in the period, with the NAV seeing a 6% increase at constant currencies.
Over 12 months, SVG’s NAV had risen 21%.
The board reported its investment portfolio saw total return of 13% over the six months, with its core investment portfolio - 50% of the net investment portfolio - continuing to perform well with 13% total return as well.
Private healthcare provider Spire Healthcare was also surging on Friday following a report that peer Mediclinic was preparing a bid for the remainder of the company.
Betaville cited people familiar with the matter as saying that Mediclinic was working with Morgan Stanley and could be weeks away from submitting a formal approach for Spire.
The offer was seen to be at a 30% premium to Spire Healthcare’s current share price.
In June 2015, South Africa’s Mediclinic bought a 29.9% stake in Spire from private equity group Cinven for 360p a share.
Acacia Mining was under pressure, after it earlier reiterated its full-year production guidance for its Bulyanhulu mine and for the group as a whole, despite setbacks in resuming production at its processing plant at the former site following planned maintenance.
Thanks to the strong performance to date at North Mara, one of its three mines in operation in Tanzania, the outfit still expected its total third quarter output to be in line with that of the first quarter.
The gold miner carried out a two-week shutdown of its vertical shaft at Bulyanhulu to modernise the production and service winders. In parallel, a programme of works was undertaken on the process plant.
FTSE 250 - Risers
Spire Healthcare Group (SPI) 406.60p 12.66%
Euromoney Institutional Investor (ERM) 1,172.00p 6.26%
Galliford Try (GFRD) 1,276.00p 5.37%
SVG Capital (SVI) 682.00p 4.84%
Evraz (EVR) 136.90p 4.50%
Countrywide (CWD) 237.70p 3.75%
JRP Group (JRP) 119.20p 3.65%
Millennium & Copthorne Hotels (MLC) 450.90p 3.63%
BTG (BTG) 637.50p 3.57%
Genus (GNS) 2,019.00p 3.54%
FTSE 250 - Fallers
Acacia Mining (ACA) 453.70p -9.26%
Centamin (DI) (CEY) 137.20p -3.24%
Debenhams (DEB) 57.05p -2.56%
Bovis Homes Group (BVS) 860.00p -2.16%
Aldermore Group (ALD) 169.10p -1.74%
Amec Foster Wheeler (AMFW) 537.50p -1.74%
Ashmore Group (ASHM) 346.20p -1.73%
McCarthy & Stone (MCS) 167.80p -1.64%
Polymetal International (POLY) 989.50p -1.64%
Petrofac Ltd. (PFC) 801.00p -1.42%